Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
01801
01801
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
01801 News
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
3d ago
aastocks
HSI Rises by 155 Points Driven by Surge in AI and Pharmaceutical Stocks
6d ago
aastocks
<Daily Summary> HSI Ends at 27,183, Gaining 155 Points; HSTI Finishes at 5,451, Up 33 Points; CSPC PHARMA Surges Over 5%; ZTO EXPRESS-W, WH GROUP, BOC HONG KONG, WHARF REIC, and HANG LUNG PPT Reach New Peaks; Market Activity Increases
6d ago
aastocks
HSI Gains 146 Points at Midday; AI and Pharmaceutical Stocks Surge; KNOWLEDGE ATLAS Jumps 21%
6d ago
aastocks
Midday Update: HSI Ends at 27,173, Gaining 146 Points; HSTI Reaches 5,463, Up 45 Points; MEITUAN Falls Over 3%; YUM CHINA, BOC HONG KONG, HSBC HOLDINGS, DAHSING BANKING, and KB LAMINATES Achieve New Highs
6d ago
aastocks
JPM Assigns HKD111 Target Price to INNOVENT BIO; Strategic Alliance with Eli Lilly Exceeds Expectations
6d ago
aastocks
UBS Anticipates Benefits from INNOVENT BIO's Collaboration with Eli Lilly for Drug Development Goals
6d ago
aastocks
CLSA Increases INNOVENT BIO's Target Price to HKD130.2, Maintains Overweight Rating
6d ago
aastocks
<Full-day Summary> HSI Gains 467 Points; HSTI Rises 71 Points; PING AN Surges Over 4%; SHK PPT, HSBC HOLDINGS, YUM CHINA, GALAXY ENT, HENDERSON LAND Reach New Peaks; Market Turnover Increases
Feb 09 2026
aastocks
<Midday Update> HSI Rises by 385 Points; HSTI Gains 55 Points; PING AN Surges Over 4%; YUM CHINA, LI NING, SHK PPT, BOC HONG KONG, and ZTO EXPRESS-W Reach New Peaks
Feb 09 2026
aastocks
G Sachs Assigns Buy Rating to INNOVENT BIO Following Strengthened Long-term Collaboration with Eli Lilly
Feb 09 2026
aastocks
CICC: INNOVENT BIO (01801.HK) Sees Robust Growth Driven by Innovation; 2026 Earnings Outlook Upgraded
Feb 09 2026
aastocks
BofAS Maintains Buy Rating on INNOVENT BIO with Target Price of HKD 113.5
Feb 09 2026
aastocks
INNOVENT BIO Rises Approximately 6% Following Global Partnership with Eli Lilly
Feb 09 2026
aastocks
<Research>HSBC Identifies Hong Kong Stocks Receiving the Most Institutional Interest (Table)
Jan 27 2026
aastocks
Guosen Securities Reveals Top 10 HK Stocks with Highest Foreign Capital Inflows and Outflows in Q4 2025 (Table)
Jan 22 2026
aastocks
Show More News
